跳至主要内容
临床试验/NL-OMON51738
NL-OMON51738尚未招募不适用

Prediction of dietary intervention efficacy in mild ulcerative colitis patients based on fecal microbiome signatures - PREDUCTOME study

Wageningen Universiteit0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • 1. Male and female subjects aged 18 to 65 years
  • 2. Body Mass Index (BMI) between 18 and 30 kg/m2 (self-reported)
  • 3. Ulcerative Colitis confirmed via previous endoscopy and histology
  • 4. Mild active UC as defined by Patient Simple Clinical Colitis Activity Index
  • (P-SCCAI) score of 3 to 5 (range 0 to 19)
  • 5. Frequent relapse (at least one exacerbation in the last two years)
  • 6. No known allergy to any components of the study product (self-reported)
  • 7. Signed informed consent
  • 8. Stable UC medication defined as no switch to other medication or no dose
  • 9. mobile phone on which apps (used for questionnaires) can be downloaded
  • (iOS version 9 and newer, Android version 4.4 and newer. Phones manufactured
  • after 2013 are usually suitable)
  • 10. stable dietary pattern during the study

排除标准

  • 1. Any other underlying disease of the GI-tract or previous bowel surgery,
  • except cholecystectomy and appendectomy
  • 2. Pregnancy or intending to become pregnant during the study
  • 3. Use of medication that can interfere with the study outcomes, as judged by
  • the medical supervisor
  • 4. The need for antibiotic use during the study period
  • 5. Systemic antibiotics and proton pump inhibitors (except for omeprazole and
  • pantoprazole with dosage <20 mg), prebiotic supplements, probiotic supplements
  • four weeks prior to study start.
  • 6. Currently participating in another intervention study
  • 7. Acquaintances of anyone in the research team

研究者

相似试验